Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib in Keratocystic Odontogenic Tumors
NCT02366312Phase 2Completed
- Sponsor
- New York University College of Dentistry
- Start
- Oct 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in Odontogenic keratocyst (OKC), sponsored by New York University College of Dentistry. Started Oct 2015; status: completed.
02
Drugs
vismodegib
03
Conditions
Odontogenic keratocyst (OKC)
Beyond the preview
Go deeper on NCT02366312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366312.